Phase 4 Pancreatic Cancer Trial, Recruiting (NCT05784311)

Phase 4 Pancreatic Cancer Trial, Recruiting NCT05784311 Sponsor: Leiden University Medical Center Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05784311 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are scheduled to have a planned (non-emergency) surgical procedure called a pancreatoduodenectomy (a major operation involving the pancreas and nearby organs), and who have a higher chance of having bacteria in their bile — either because they had a tube placed before surgery to drain their bile, or because they have a type of tumour near the bile duct opening.
People who are over 18 years of age.

Who may not be able to join:

People who are pregnant.
People who have an allergy or intolerance to the antibiotics being studied in this trial.
People who are already planned to take antibiotics before surgery to treat an active infection, such as an infection in the bile duct or liver.
People whose kidneys are not working well enough, based on a specific blood test result measured before surgery (confirm with trial site for exact threshold).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: J. Sven D. Mieog, MD PhD, Leiden University Medical Center

Phone: 071 5261334

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05784311

Sponsor: Leiden University Medical Center

Phase: Phase 4

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: 071 5261334

More information: https://clinicaltrials.gov/study/NCT05784311

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are scheduled to have a planned (non-emergency) surgical procedure called a pancreatoduodenectomy (a major operation involving the pancreas and nearby organs), and who have a higher chance of having bacteria in their bile — either because they had a tube placed before surgery to drain their bile, or because they have a type of tumour near the bile duct opening.
People who are over 18 years of age.

Who may not be able to join:

People who are pregnant.
People who have an allergy or intolerance to the antibiotics being studied in this trial.
People who are already planned to take antibiotics before surgery to treat an active infection, such as an infection in the bile duct or liver.
People whose kidneys are not working well enough, based on a specific blood test result measured before surgery (confirm with trial site for exact threshold).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Leiden University Medical Center

Registry

ClinicalTrials.gov

Start date

6 March 2023

Est. completion

1 July 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Rate of clinically relevant organ/space surgical site infection (OSI) between patients with perioperative versus prolonged antibiotic prophylaxis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov